Eng-Wong J - Search Results

1

A phase I trial and pharmacokinetic study of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in metastatic breast cancer.

Lebowitz PF, Eng-Wong J, Widemann BC, Balis FM, Jayaprakash N, Chow C, Clark G, Gantz SB, Venzon D, Zujewski J. Lebowitz PF, et al. Clin Cancer Res. 2005 Feb 1;11(3):1247-52. Clin Cancer Res. 2005. PMID: 15709195 Clinical Trial.

2

A pilot study of dose intense doxorubicin and cyclophosphamide followed by infusional paclitaxel in high-risk primary breast cancer.

Zujewski JA, Eng-Wong J, O'Shaughnessy J, Venzon D, Chow C, Danforth D, Kohler DR, Cusack G, Riseberg D, Cowan KH. Zujewski JA, et al. Breast Cancer Res Treat. 2003 Sep;81(1):41-51. doi: 10.1023/A:1025421416674. Breast Cancer Res Treat. 2003. PMID: 14531496 Clinical Trial.

3

Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer.

Eng-Wong J, Hursting SD, Venzon D, Perkins SN, Zujewski JA. Eng-Wong J, et al. Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1468-73. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14693739 Clinical Trial.

4

A phase II trial of neoadjuvant docetaxel and capecitabine for locally advanced breast cancer.

Lebowitz PF, Eng-Wong J, Swain SM, Berman A, Merino MJ, Chow CK, Venzon D, Zia F, Danforth D, Liu E, Zujewski J. Lebowitz PF, et al. Clin Cancer Res. 2004 Oct 15;10(20):6764-9. doi: 10.1158/1078-0432.CCR-04-0976. Clin Cancer Res. 2004. PMID: 15501952 Clinical Trial.

5

Sentinel lymph node biopsy in the management of ductal carcinoma in situ.

Zujewski J, Eng-Wong J. Zujewski J, et al. Clin Breast Cancer. 2005 Aug;6(3):216-22. doi: 10.3816/CBC.2005.n.023. Clin Breast Cancer. 2005. PMID: 16137431 Review.

6

Effects of raloxifene on circulating prolactin and estradiol levels in premenopausal women at high risk for developing breast cancer.

Faupel-Badger JM, Prindiville SA, Venzon D, Vonderhaar BK, Zujewski JA, Eng-Wong J. Faupel-Badger JM, et al. Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1153-8. doi: 10.1158/1055-9965.EPI-05-0898. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16775175 Clinical Trial.

7

Effect of raloxifene on bone mineral density in premenopausal women at increased risk of breast cancer.

Eng-Wong J, Reynolds JC, Venzon D, Liewehr D, Gantz S, Danforth D, Liu ET, Chow C, Zujewski J. Eng-Wong J, et al. J Clin Endocrinol Metab. 2006 Oct;91(10):3941-6. doi: 10.1210/jc.2005-2827. Epub 2006 Jul 25. J Clin Endocrinol Metab. 2006. PMID: 16868059 Clinical Trial.

8

Effect of raloxifene on salivary sex steroid concentrations in premenopausal women.

Chatterton RT Jr, Zujewski J, Mateo ET, Eng-Wong J, Jordan VC. Chatterton RT Jr, et al. J Endocrinol. 2006 Dec;191(3):599-604. doi: 10.1677/joe.1.06791. J Endocrinol. 2006. PMID: 17170217 Clinical Trial.

9

Gynecologic and hormonal effects of raloxifene in premenopausal women.

Premkumar A, Venzon DJ, Avila N, Johnson DV, Remaley AT, Forman MR, Eng-Wong J, Zujewski J, Stratton P. Premkumar A, et al. Fertil Steril. 2007 Dec;88(6):1637-44. doi: 10.1016/j.fertnstert.2007.01.095. Epub 2007 Jul 26. Fertil Steril. 2007. PMID: 17662283 Free article. Clinical Trial.

10

Current NCI-sponsored Cooperative Group trials of endocrine therapies in breast cancer.

Eng-Wong J, Zujewski JA. Eng-Wong J, et al. Cancer. 2008 Feb 1;112(3 Suppl):723-729. doi: 10.1002/cncr.23188. Cancer. 2008. PMID: 18072276 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters